Non-selective beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of randomized trials-Reference-Cited by-同舟云学术

Non-selective beta-blockers may reduce risk of hepatocellular carcinoma: a meta-analysis of randomized trials

Published:2015-02-06 Issue:8 Volume:35 Page:2009-2016
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Thiele Maja¹,Albillos Agustín²,Abazi Rozeta¹,Wiest Reiner³,Gluud Lise L.⁴,Krag Aleksander¹

Affiliation:

1. Department of Gastroenterology and Hepatology; Odense University Hospital; Odense Denmark

2. Department of Gastroenterology and Hepatology; Centro de Investigación Biomédica en Red en Enfermedades Hepáticas y Digestivas (CIBERehd); Institute of Health Carlos III; University Hospital Ramón y Cajal; University of Alcalá; IRYCIS; Madrid Spain

3. Department for Visceral Surgery and Medicine; University Hospital Bern; Bern Switzerland

4. Gastro unit; Copenhagen University Hospital Hvidovre; Hvidovre Denmark

Funder

University of Southern Denmark

Danish Advanced Technology Foundation

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12782/fullpdf

Reference51 articles.

1. IARC, WHO, Globocan Liver cancer estimated incidence, mortality and prevalence worldwide 2012 http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx

2. Epidemiology of viral hepatitis and hepatocellular carcinoma;El-Serag;Gastroenterology,2012

3. Reduced mortality with non-selective betablockers compared to banding is not related to prevention of bleeding or bleeding related mortality: systematic review of randomized trials;Krag;J Hepatol,2011

4. Can non-selective beta-blockers prevent hepatocellular carcinoma in patients with cirrhosis?;Thiele;Med Hypotheses,2013

5. The beta-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor kappaB signaling;Liao;Oncol Rep,2010

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Portal hypertension is associated with poorer outcome and clinical liver decompensation in patients with HCC treated with Atezolizumab-Bevacizumab;Digestive and Liver Disease;2024-09

2. Hipertensión portal en el paciente cirrótico, varices esofágicas, gastropatía y sangrado digestivo;Medicine - Programa de Formación Médica Continuada Acreditado;2024-05

3. Heart failure pharmacotherapy and cancer: pathways and pre-clinical/clinical evidence;European Heart Journal;2024-03-05

4. The prognostic value of beta-1 blockers in patients with non-small-cell lung carcinoma treated with pembrolizumab;International Journal of Cardiology;2024-02

5. Portosystemic shunting prevents hepatocellular carcinoma in non-alcoholic fatty liver disease mouse models;PLOS ONE;2023-12-29